BDB551900

CD32 Mouse anti-Human, Unlabeled, Clone: 3D3, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB551900-Each-of-1 In Stock ₹ 15,486.00

BDB551900 - Each of 1

₹ 15,486.00

In Stock

Quantity

1

Base Price: ₹ 15,486.00

GST (18%): ₹ 2,787.48

Total Price: ₹ 18,273.48

Antigen

CD32

Classification

Monoclonal

Concentration

0.5mg/mL

Description

FcγRII

Host Species

Mouse

Quantity

0.1 mg

Research Discipline

Immunology

Target Species

Human

Isotype

IgG1 κ

Applications

Flow Cytometry

Clone

3D3

Conjugate

Unconjugated

Formulation

Aqueous buffered solution containing ≤0.09% sodium azide.

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C

Related Products

Img

BD Biosciences

BDB552727

--

Img

BD Biosciences

BDB555587

--

Img

BD Biosciences

BDB555625

--

Img

BD Biosciences

BDB555370

--

Img

BD Biosciences

BDB555458

--

Img

BD Biosciences

BDB555767

--

Img

BD Biosciences

BDB555772

--

Img

BD Biosciences

BDB555685

--

Description

  • Reacts with FcγRII (CD32), a 40 kDa, polymorphic transmembranous glycoprotein, highly glycosylated molecule (encoded by at least two genes), expressed on monocytes, granulocytes, platelets and B cells
  • Unlike FLI28.6, 3D3 mAb detected a polymorphic CD32 antigen expressed on B cells of all donors, but only on platelets, monocytes and granulocytes of some donors
  • The platelets from 3D3+ donors respond to certain stimulatory mAb such as CD165 (clone SN2, Cat
  • No
  • 556050) and result in aggregation
  • On the other hand, the platelets from 3D3 negative donors do not form aggregates after stimulation
  • Individuals can be divided into two groups as responder and non-responder depending on expression, or non-expression, of 3D3
  • In comparison to 3D3, FLI8.26 detects a monomorphic CD32 antigen expressed on all human donors
  • This antibody is routinely tested by flow cytometric analysis
  • Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.